There were a lot of contradicting headlines concerning the timeline following the rollout of a vaccine once one of the top candidates. As a reminder, the top candidates are from Moderna, Pfizer-BioNTech, AstraZeneca, and the University of Oxford.
Now, Paul Mango, deputy chief of staff at Health and Human Services, said earlier Wednesday that he believed that Americans will be able to get a COVID-19 vaccine by the end of the first quarter 2021, roughly April.
Even if a vaccine were to receive an Emergency Use Authorization, which will be the regulatory approval needed, it would take time to fully roll out that vaccine. Public health officials are eyeing a tiered response, so frontline workers, healthcare workers, high-risk and the elderly will be among the first to receive a vaccine. The Center for Disease Control and an advisory committee have been working on a ranking system for a full vaccine rollout.
However, Robert Redfield, CDC director, said in a Senate testimony that he believes that it’s more likely that a vaccine is rolled out in late Q2 or Q3 of 2021.
And Dr. Anthony Fauci said that it’s “possible but tough” to vaccinate everyone by April 2021, and it’s more likely to have access by the middle or end of 2021.
Redfield added, “Early in (the) COVID-19 vaccination program there may be a limited supply of vaccine and vaccine efforts may focus on those critical to the response, providing direct care and maintaining societal functions, as well as those at highest risk for developing severe illness.”
And he discussed face masks and vaccines, “This face mask is more guaranteed to protect me against COVID than when I take a COVID vaccine ... if I don't get an immune response, the vaccine's not going to protect me. This face mask will."
Earlier this week, TheStreet’s Katherine Ross talked to Raymond James analyst Steven Seedhouse, who told me, “there's a possibility that the vaccines just aren't effective enough...to open up everything, stop wearing masks, and stop mitigation metrics.”
Moderna's CEO, Thursday morning, said that a widespread vaccine could possibly take until Labor Day of next year. CEO Stephane Bancel said, "I anticipate that the world is going to be massively supply-constrained, meaning not enough vaccine to vaccinate everybody.”
Latest Videos From TheStreet and Jim Cramer:
- The Fed’s New Policy — Everything You Need to Know
- What Has Jim Cramer So Concerned About the Economy
- Coronavirus Update: Eli Lilly and Amgen to Manufacture Possible COVID-19 Drugs
- Jobless Claims Reflect Slowing Economic Recovery
- Peloton Is an Ecosystem, Apple Isn't a Competitor, Jim Cramer Says
- Sumo Logic Joins Snowflake and JFrog in Software IPO Frenzy
- Big Ten Announces Return: Top Stories, Sports and Business News — Sept. 16
- McDonald's Collaboration With Rapper Travis Scott Proved to be a Hit